Company profile for Ventus Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Ventus, we are focused on discovering and developing novel therapeutics that target the innate immune system with the goal of addressing autoimmune diseases, inflammatory diseases, and cancer. We are uniquely enabled by our field-leading structural immunology platform, a highly experienced management and drug discovery team that has delivered multiple marketed compounds, and leading academics spanning the fields of struc...
At Ventus, we are focused on discovering and developing novel therapeutics that target the innate immune system with the goal of addressing autoimmune diseases, inflammatory diseases, and cancer. We are uniquely enabled by our field-leading structural immunology platform, a highly experienced management and drug discovery team that has delivered multiple marketed compounds, and leading academics spanning the fields of structural biology and immunology. Guided by a patient-centric ethos, our aim is to rapidly advance multiple drug candidates. Our emerging pipeline focuses on the inflammasome and nucleic acid sensing pathways.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
21 Strathmore Rd. Natick, Massachusetts 01760
Telephone
Telephone
514-397-9517
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251020110977/en/Ventus-Therapeutics-Enters-into-a-Collaboration-and-License-Agreement-with-Genentech-to-Discover-and-Develop-Small-Molecule-Medicines-Using-Ventus-ReSOLVE-Platform

BUSINESSWIRE
21 Oct 2025

https://www.businesswire.com/news/home/20250903331638/en/Ventus-Therapeutics-to-Present-at-Morgan-Stanley-23rd-Annual-Global-Healthcare-Conference

BUSINESSWIRE
04 Sep 2025

https://www.businesswire.com/news/home/20250521929176/en/Ventus-Therapeutics-to-Present-Phase-1-Results-for-VENT-03-a-First-in-Class-cGAS-Inhibitor-at-LUPUS-2025

BUSINESSWIRE
22 May 2025

https://www.businesswire.com/news/home/20250425824044/en/Ventus-Therapeutics-to-Present-at-2025-Bloom-Burton-Co.-Healthcare-Investor-Conference

BUSINESSWIRE
29 Apr 2025

https://www.businesswire.com/news/home/20250324542820/en/Ventus-Therapeutics-Announces-Publication-in-Natures-Communications-Chemistry-Describing-the-Structure-based-Optimization-of-a-New-Series-of-cGAS-Inhibitors

BUSINESSWIRE
25 Mar 2025

https://www.businesswire.com/news/home/20250307125796/en

BUSINESSWIRE
10 Mar 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty